<?xml version="1.0" encoding="UTF-8"?>
<p>A few published studies have analyzed the risks of rheumatologic patients using bDMARDs and CHIKV-infected patients, and published results are similar to those in our study, although with different methodologies [
 <xref rid="B15" ref-type="bibr">15</xref>, 
 <xref rid="B16" ref-type="bibr">16</xref>].
</p>
